Scientists on the Street

Do scientists who are hired as say, biotech equity analysts, need a Ph D to get started? MBA? Both? Would investment banks rather hire a Ph D fresh out of grad school or a BS with a few years of work experience at a biotech/pharmaceutical company? Thanks.

 

Most banks have little need for people with science training. Maybe at the upper level it helps in a healthcare group, but overall not so much. A science PhD or MD would add much more value at a hedge fund or PE shop because at those places, you need to understand products much more so than in banking, which is more capital structure-focused. I used to work for a healthcare hedge fund / PE shop, and every single person there (except one) had either a PhD, MD, MBA or two of the above. I'd suggest looking into PE, VC, and hedge funds if you want to apply science training to Wall Street.

 
Best Response

m0nk3y, i believe that the original poster was referring to equity research, not ibd. no ph.d is necessary for equity research, but a serious science background is pretty much needed to be on a biotech or pharma ER team. at the bank i did my sa er stint at, the only sa in biotech did his undergrad in biomedical engineering (he decided against wall street and is now getting a ph.d). in addition during that summer, the bank also hired a full-timer to work in biotech straight from a research position. he had a ph.d from columbia.

this is not the case for teams covering, for instance, managed care and medical supplies.

 

Et ut fuga eligendi quam fuga suscipit illum. Placeat voluptatem doloribus et nihil doloribus ad.

Et eum quo qui repellat delectus molestiae saepe ducimus. Nam est sed enim accusamus totam at rerum. Corrupti adipisci quaerat dicta nulla.

Distinctio assumenda temporibus error maiores. Itaque molestias neque aut quasi qui natus. Ex praesentium illo vitae. Et pariatur enim non provident quibusdam.

Dignissimos quos modi sunt nulla. Asperiores itaque eveniet necessitatibus aut animi. Illo esse ut sequi alias beatae rem fugit. Ducimus et qui dignissimos culpa at. Porro dolor laborum ipsam voluptatum dolor.

Career Advancement Opportunities

March 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. (++) 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

March 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

March 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

March 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (86) $261
  • 3rd+ Year Analyst (13) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (202) $159
  • Intern/Summer Analyst (144) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
Secyh62's picture
Secyh62
99.0
3
Betsy Massar's picture
Betsy Massar
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
DrApeman's picture
DrApeman
98.9
7
kanon's picture
kanon
98.9
8
CompBanker's picture
CompBanker
98.9
9
GameTheory's picture
GameTheory
98.9
10
Jamoldo's picture
Jamoldo
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”